Journal
INTERNATIONAL CANCER CONFERENCE JOURNAL
Volume 12, Issue 3, Pages 168-172Publisher
SPRINGER INT PUBL AG
DOI: 10.1007/s13691-023-00599-6
Keywords
Advanced corpus cancer; Late recurrence; Hormone replacement therapy
Categories
Ask authors/readers for more resources
This article reports a case of advanced corpus cancer in a young patient who initiated hormone replacement therapy (HRT) 7 years post-surgery and later experienced regional lymph node recurrence. The authors hypothesize that HRT did not induce tumor recurrence but instead allowed for long-term follow-up and early diagnosis.
There is no consensus on the use of hormone replacement therapy (HRT) after treatment of advanced corpus cancer. We report a case of advanced corpus cancer at a young age, in which HRT was initiated 7 years after surgery, and regional lymph node recurrence was later detected. The patient was 35 years old at the time of initial treatment in X year, when she was diagnosed with stageIIIC2 corpus cancer and underwent a hysterectomy with bilateral salpingo-oophorectomy and a retroperitoneal lymphadenectomy. HRT was started at X + 7 years, and at X + 9 years, a 25 x 12-mm-sized mass was found in the hilum of the right kidney. A laparoscopic resection revealed regional lymph node recurrence of the corpus cancer. A retrospective study further revealed that a tumor measuring 12 x 3 mm was found at X + 3 years and grew to 18 x 7 mm in X + 6 years, just before the start of the HRT. We hypothesize that HRT did not induce tumor recurrence; instead, it allowed for long-term follow-up and early diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available